What is news is that finally researchers have the actual genome, we have the data, but now the data is in widespread distribution.

Despite the efficacy advantage, CAIV-T will have to overcome its premium pricing and lingering safety concerns. Physicians may not be comfortable using a live vaccine in small children.

The news just seems to follow the markets,

great news. A half-million dollars toward a problem we’ve been struggling with for so long is a great benefit to out city, especially around the old Wehadkee site and in Knoxville.

heard it on the news.

It's very good news for creditors who can start getting paid again.